Quantify’s Mathias Lilja and Johan Mesterton are co-authors on a new study on cytarabine dosing for treating secondary and high-risk AML using a synthetic control arm study design.
Since 1980’s, the standard treatment of acute myeloid leukemia (AML) is cytarabine infusion […]
In December 2023, Quantify’s Stuti Arya, Nicholas Norton and Puneet Kaushik published a study assessing recent changes to adult national immunization programs for pneumococcal vaccination and attempting to determine how those changes impacted coverage in European Adults. The review revealed […]
The entire team here at Quantify is extremely excited to announce that we are opening our doors in Finland. Even though we have a long history of working with Finnish RWE and market access, our new local presence will help […]
Understanding how payers value a quality-adjusted life year (QALY) is crucial. We often are asked about the Swedish payer TLV’s willingness to pay (WTP) thresholds for one QALY, and whether the usually cited levels of WTP by severity are used […]
This Wednesday January 24th, Quantify’s Emilie Toresson Grip, Head of RWE and Analytics, will hold a presentation on this topic at the Centre for Bioinformatics and Biostatistics (CBB) at Karolinska Institutet.
Emilie will present a case example […]
Hopes are high for the first disease modifying treatments in Alzheimer’s disease to be approved on the European market, but many challenges remain. Quantify Research colleagues Anders Gustavsson and Lena Jacobs are […]
The natural history of severe asthma is complex and poorly understood, and until recently we were unable to effectively predict the progression of the disease. To shed light on this important area, we are delighted to share our latest study […]
Extensive article today in the Swedish newspaper Dagens Nyheter on the increasing burden of fatty liver disease (NAFLD), including an interview with Associate Professor Hannes Hagström, co-creater of the HERALD liver data platform together with Quantify Researchs Emilie […]
Quantify is proud to introduce Zoltán Németh, who will strengthen our Modelling, Access, and Strategy team in Stockholm as Senior Research Analyst. Zoltán holds a degree in Health Economics, Policy, and […]